Table 2 The clinical features of the LAC specimens used in this study
From: SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma
| Â | WHO grade | ||
|---|---|---|---|
Feature | I (n = 11) | II (n = 73) | III (n = 8) |
Gender | |||
 Male | 7 | 38 | 6 |
 Female | 4 | 35 | 2 |
Age at diagnosis | |||
 <60 | 5 | 25 | 3 |
 ≥ 60 | 6 | 48 | 5 |
T stage | |||
 T1–2 | 11 | 54 | 4 |
 T3–4 | 0 | 19 | 4 |
N stage | |||
 N0 | 9 | 34 | 4 |
 N1–3 | 2 | 39 | 4 |
TNM stage | |||
 I | 8 | 25 | 2 |
 II | 3 | 22 | 2 |
 III | 0 | 26 | 4 |
Location | |||
 Left | 3 | 26 | 4 |
 Right | 8 | 47 | 4 |